Diabetes

Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits.

Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality.

Answers to common questions about insulin pump therapy.

Any support you can provide to your sight-impaired patients can help keep them self-sufficient in their diabetes management.

Get the info you need on these new drugs, part of our drug news roundup for September.

Obesity Canada has updated its recommendations on pharmacotherapy for obesity management in adults. Have you kept up? Find out here!

By tracking weather conditions and consumer purchases, the researchers found that sugar consumption rose as temperatures moved between about 12 and 30 Celsius.

Study assesses the safety and efficacy of canagliflozin in children and adolescents with type 2 diabetes who are inadequately controlled on metformin and/or insulin.